Video Latest - ecancer

ESMO 2018: Highlights

Prof Gordon McVie , Will Davies

22 Oct 2018

The TRIBE-2 study for colorectal cancer

Dr Chiara Cremolini - Università di Pisa, Pisa, Italy

22 Oct 2018

The microbiome – a novel paradigm in oncology research

Dr Alasdair Scott - Imperial College London, London, UK

5 Sep 2018

The ICMC: a new path for microbiome research

Prof Julian Marchesi - Imperial College London, London, UK

19 Jul 2018

The microbiome and cancer: cause or correlation?

Dr James Kinross - Imperial College London, London, UK

19 Jul 2018

MyPathway study: a novel precision oncology multiple basket trial

Dr Mary S. Beattie - Genentech, USA

6 Jul 2018

Editor's Choice for June 2018

Prof Gordon McVie - Founding Editor, ecancer

4 Jul 2018

ASCO 2018 conference round up

Dr Bishal Gyawali and Will Davies

24 Jun 2018

Results from the phase I ICONIC trial

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA

4 Jun 2018

Aspirin combined with acid-reducing medicine offers moderate benefits in patients with Barrett’s oesophagus

Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic of Ireland

4 Jun 2018

Heated abdominal chemotherapy not beneficial in patients with advanced colorectal cancer

Dr Francois Quenet - Regional Cancer Institute, Montpellier, France

4 Jun 2018

Comment: Aspirin with acid-reducing medicine reduces chance of oesophageal cancer in high risk individuals

Dr Andrew Epstein and Prof Richard Schilsky

4 Jun 2018

Video